MMA Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,695
Closed -$293K 101
2021
Q4
$293K Buy
1,695
+78
+5% +$11.9K 0.21% 68
2021
Q3
$235K Hold
1,617
0.18% 80
2021
Q2
$213K Buy
+1,617
New +$212K 0.16% 88

Other funds holding DGX

MMA Asset Management's DGX Position: Q1 2022 in Review

MMA Asset Management sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 1,695 shares — an estimated $293K sold.

MMA Asset Management first reported a position in DGX in Q2 2021 and held it in 3 quarters. The position peaked at $293K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • MMA Asset Management reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • MMA Asset Management sold 1,695 Quest Diagnostics shares in Q1 2022, an estimated $293K.
  • MMA Asset Management first reported a position in Quest Diagnostics in Q2 2021 and held it in 3 quarters.
  • MMA Asset Management's Quest Diagnostics position peaked at $293K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on MMA Asset Management's 13F filing for Q1 2022, filed 13 May 2022.